Elai Davicioni

Also affiliated with Veracyte (United States), ViaCyte (United States), Incyte (United States)

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile

0.739Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Transcriptome profiling of NRG Oncology/RTOG 9601: Validation of a prognostic genomic classifier in salvage radiotherapy prostate cancer patients from a prospective randomized trial.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.276

Top 39%

0.489DataRank

Top 39%11 citations

Howard M. Sandler, Huei–Chung Huang, Jeffry Simko, Elai Davicioni, Paul L. Nguyen +15 more

Papers

Driven by 48 papers — median percentile 51. Top paper: “Analysis of a Biopsy-Based Genomic Classifier in High-Risk Prostate Cancer: Meta-Analysis of the NRG Oncology/Radiation Therapy Oncology Group 9202, 9413, and 9902 Phase 3 Randomized Trials”.

Analysis of a Biopsy-Based Genomic Classifier in High-Risk Prostate Cancer: Meta-Analysis of the NRG Oncology/Radiation Therapy Oncology Group 9202, 9413, and 9902 Phase 3 Randomized Trials

International Journal of Radiation Oncology*Biology*Physics(2022)10.1016/j.ijrobp.2022.12.035

N/A

1.1DataRank · unranked

51 citations

Huei–Chung Huang, Daniel E. Spratt, Elai Davicioni, Howard M. Sandler, William U. Shipley +17 more

Genomic Testing in Localized Prostate Cancer Can Identify Subsets of African Americans With Aggressive Disease

JNCI Journal of the National Cancer Institute(2022)10.1093/jnci/djac162

N/A

1.1DataRank · unranked

24 citations

G. Daniel Grass, Javier F. Torres–Roca, Peter A.S. Johnstone, Julio M. Pow‐Sang, Jasreman Dhillon +27 more

Variation in Molecularly Defined Prostate Tumor Subtypes by Self-identified Race

European Urology Open Science(2022)10.1016/j.euros.2022.03.014

N/A

0.867DataRank · unranked

12 citations

Shivanshu Awasthi, Mohamed Alshalalfa, Bruce J. Trock, Stephen J. Freedland, Michael R. Freeman +13 more

Transcriptional profiling of primary prostate tumor in metastatic hormone-sensitive prostate cancer and association with clinical outcomes: correlative analysis of the E3805 CHAARTED trial

Annals of Oncology(2021)10.1016/j.annonc.2021.06.003

N/A

0.654DataRank · unranked

77 citations

Hsin-Chieh Huang, V. Wang, Yu‐Hui Chen, Felix Y. Feng, Robert B. Den +11 more

Transcriptome profiling of NRG Oncology/RTOG 9601: Validation of a prognostic genomic classifier in salvage radiotherapy prostate cancer patients from a prospective randomized trial.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.276

Top 39%

0.489DataRank

Top 39%11 citations

Howard M. Sandler, Huei–Chung Huang, Jeffry Simko, Elai Davicioni, Paul L. Nguyen +15 more

Transcriptomic Profiling of Primary Prostate Cancers and Nonlocalized Disease on Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography: A Multicenter Retrospective Study

JCO Precision Oncology(2024)10.1200/po.24.00161

Top 60%

0.250DataRank

Top 60%2 citations

Kritika Subramanian, Nimrod Barashi Gozal, Andres Ricaurte‐Fajardo, Eric V. Li, James A. Proudfoot +20 more

Transcriptomic Analysis of Localized High-risk Prostate Cancer Improves Prognostication and Identifies Benefit from Adding Docetaxel to Definitive Radiotherapy with Androgen Suppression in the NRG Oncology/RTOG 0521 Phase 3 Trial

European Urology Oncology(2025)10.1016/j.euo.2025.04.009

N/A

0.214DataRank · unranked

3 citations

James A. Proudfoot, Elai Davicioni, Yang Liu, Daniel E. Spratt, Jeffry Simko +17 more

A prospective validation of the genomic classifier to define high-metastasis risk in a subset of African American men with early localized prostate cancer: VanDAAM study.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.5005

N/A

0.201DataRank · unranked

2 citations

Jasreman Dhillon, Peter A.S. Johnstone, Julio M. Pow‐Sang, Elai Davicioni, Angelina Fink +15 more

Reshaping of the androgen-driven chromatin landscape in normal prostate cells by early cancer drivers and effect on therapeutic sensitivity

Cell Reports(2021)10.1016/j.celrep.2021.109625

N/A

0DataRank · unranked

49 citations

Michael A. Augello, Deli Liu, Dylan McNally, Christopher Gaffney, Dennis Huang +12 more

Prostate-specific Membrane Antigen and Fluciclovine Transporter Genes are Associated with Variable Clinical Features and Molecular Subtypes of Primary Prostate Cancer

European Urology(2021)10.1016/j.eururo.2021.03.017

N/A

0DataRank · unranked

18 citations

Mohammed Alshalalfa, Martin Sjöström, Shuang G. Zhao, Yang Liu, Jonathan Chou +17 more

Prostate cancer in young men represents a distinct clinical phenotype: gene expression signature to predict early metastases

Journal of Translational Genetics and Genomics(2021)10.20517/jtgg.2021.01

N/A

0DataRank · unranked

2 citations

Huiqing Wu, Elai Davicioni, R. Jeffrey Karnes, Eric A. Klein, Robert B. Den +3 more

Prospective randomized trial of gene expression classifier utility following radical prostatectomy (G-MINOR).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.15

N/A

0DataRank · unranked

6 citations

Linda A. Okoth, Daniel E. Spratt, Rodney L. Dunn, Felix Y. Feng, Anna Johnson +16 more

MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targets

Nature Communications(2022)10.1038/s41467-022-30257-z

N/A

0DataRank · unranked

160 citations

Nadia Boufaied, Tarek Hallal, Avery Feit, Anna de Polo, Adrienne Luoma +30 more

Genomic Classifiers in Personalized Prostate Cancer Radiation Therapy Approaches: A Systematic Review and Future Perspectives Based on International Consensus

International Journal of Radiation Oncology*Biology*Physics(2022)10.1016/j.ijrobp.2022.12.038

N/A

0DataRank · unranked

25 citations

Cédric Draulans, Amar U. Kishan, Daniel E. Spratt, Ashley E. Ross, Tobias Maurer +35 more

Transcriptomic Features of Cribriform and Intraductal Carcinoma of the Prostate

European Urology Focus(2022)10.1016/j.euf.2022.05.005

N/A

0DataRank · unranked

12 citations

Tarik Benidir, Magdalena A. Rainey, Monica Nair, Elai Davicioni, Ewan A. Gibb +9 more

Genomic biomarkers to guide precision radiotherapy in prostate cancer

The Prostate(2022)10.1002/pros.24373

N/A

0DataRank · unranked

10 citations

Matthew P. Deek, Kim Van der Eecken, Alexander W. Wyatt, Amar U. Kishan, Jason K. Molitoris +11 more

High intratumoral plasma cells content in primary prostate cancer defines a subset of tumors with potential susceptibility to immune-based treatments

Prostate Cancer and Prostatic Diseases(2022)10.1038/s41391-022-00547-0

N/A

0DataRank · unranked

8 citations

Christina Y. Yu, Mitali Kini, Yang Liu, Elai Davicioni, Antonina Mitrofanova +3 more

Transcriptomic and clinical heterogeneity of metastatic disease timing within metastatic castration-sensitive prostate cancer

Annals of Oncology(2023)10.1016/j.annonc.2023.04.515

N/A

0DataRank · unranked

28 citations

Amol C. Shetty, Alex Hakansson, Kim Van der Eecken, Yang Song, Y. Liu +27 more

Use of the Decipher genomic classifier among men with prostate cancer in the United States

JNCI Cancer Spectrum(2023)10.1093/jncics/pkad052

N/A

0DataRank · unranked

17 citations

James A. Proudfoot, Angela Y. Jia, Raed Zuhour, Randy Vince, Yang Liu +29 more

Genomic Tumor Correlates of Clinical Outcomes Following Organ-Sparing Chemoradiation Therapy for Bladder Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0792

N/A

0DataRank · unranked

17 citations

Yuzhen Zhou, Keisuke Otani, Michael Drumm, Yukako Otani, Shulin Wu +17 more

Prostate Cancer Tumor Volume and Genomic Risk

European Urology Open Science(2023)10.1016/j.euros.2022.12.002

N/A

0DataRank · unranked

11 citations

J. Proudfoot, Ashley E. Ross, Elai Davicioni, Edward M. Schaeffer, Jim C. Hu +1 more

Intratumoral androgen biosynthesis associated with 3β-hydroxysteroid dehydrogenase 1 promotes resistance to radiotherapy in prostate cancer

Journal of Clinical Investigation(2023)10.1172/jci165718

N/A

0DataRank · unranked

11 citations

Zaeem Lone, Andrew Muskara, Jarrell Imamura, Aimalie Hardaway, Mona Patel +14 more

Histology Specific Molecular Biomarkers: Ushering in a New Era of Precision Radiation Oncology

Seminars in Radiation Oncology(2023)10.1016/j.semradonc.2023.03.001

N/A

0DataRank · unranked

2 citations

Heath D. Skinner, Matthew E. Witek, Mark V. Mishra, Young Kwok, Elai Davicioni +6 more

Basal-luminal subtyping of localized high-risk prostate cancer and benefit of adding docetaxel to definitive radiotherapy with androgen suppression in the NRG Oncology/RTOG 0521 phase III trial.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5094

N/A

0DataRank · unranked

3 citations

James A. Proudfoot, Elai Davicioni, Yang Liu, Daniel E. Spratt, Felix Y. Feng +15 more

Determining the impact of genomic classifier testing on patient-reported quality of life after prostatectomy: Results from the G-MINOR randomized trial.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.6_suppl.345

N/A

0DataRank · unranked

0 citations

Stephanie Daignault‐Newton, Rodney Dunn, Daniel E. Spratt, Linda A. Okoth, Felix Y. Feng +15 more

Data from Identification of a PAX-FKHR Gene Expression Signature that Defines Molecular Classes and Determines the Prognosis of Alveolar Rhabdomyosarcomas

(2023)10.1158/0008-5472.c.6494240.v1

N/A

0DataRank · unranked

0 citations

Friedrich Graf Finckenstein, Violette Shahbazian, Jonathan D. Buckley, Timothy J. Triche, Michael J. Anderson +1 more

Radiogenomic profiling of prostate tumors prior to external beam radiotherapy converges on a transcriptomic signature of TGF-β activity driving tumor recurrence

The Medicine Forum(2023)10.1101/2023.05.01.23288883

N/A

0DataRank · unranked

0 citations

Uma Shankavaram, Shana Y. Trostel, Hong Zhang, Houssein Abdul Sater, Stephanie A. Harmon +12 more

Molecular Hallmarks of Prostate-specific Membrane Antigen in Treatment-naïve Prostate Cancer

European Urology(2024)10.1016/j.eururo.2024.09.005

N/A

0DataRank · unranked

14 citations

Raag Agrawal, Nicholas K. Wang, Ida Sonni, Eric V. Li, Jaron Arbet +22 more

Biopsy-based Basal-luminal Subtyping Classifier in High-risk Prostate Cancer: A Combined Analysis of the NRG Oncology/RTOG 9202, 9413, and 9902 Phase 3 Trials

European Urology Oncology(2024)10.1016/j.euo.2024.10.017

N/A

0DataRank · unranked

2 citations

Paul L. Nguyen, James A. Proudfoot, Yang Liu, Alan Dal Pra, Daniel E. Spratt +16 more

Tumor transcriptome-wide expression classifiers predict treatment sensitivity in advanced prostate cancers

Cell(2025)10.1016/j.cell.2025.07.042

N/A

0DataRank · unranked

24 citations

Peter Dutey‐Magni, Marina Parry, Larissa Mendes, Ashwin Sachdeva, James A. Proudfoot +42 more

Genome-scale CRISPR screens identify PTGES3 as a direct modulator of androgen receptor function in advanced prostate cancer

Nature Genetics(2025)10.1038/s41588-025-02388-8

N/A

0DataRank · unranked

6 citations

James E. Melnyk, Becky Xu Hua Fu, Raunak Shrestha, Meng Zhang, Martin Sjöström +34 more

A Randomized Controlled Phase 2 Trial Comparing Salvage Radiotherapy for Prostate Cancer Delivered in 4 Versus 2 Weeks (SHORTER): Acute Genitourinary and Gastrointestinal Patient-reported Outcomes at a Single Institution

European Urology Oncology(2025)10.1016/j.euo.2025.05.014

N/A

0DataRank · unranked

5 citations

Marshall A. Diven, Brady Rippon, Christopher E. Barbieri, Jim C. Hu, Douglas S. Scherr +20 more

Radiogenomic Profiling of Prostate Tumors prior to External Beam Radiotherapy Converges on a Transcriptomic Signature of TGF-β Activity Driving Tumor Recurrence

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-2186

N/A

0DataRank · unranked

2 citations

Uma Shankavaram, Shana Y. Trostel, Hong Zhang, Sumeyra Kartal, Houssein Abdul Sater +25 more

Characterizing population-wide genomic risk distribution for development of a novel clinical-genomic risk system for prognostication in patients with clinically localized prostate cancer

Prostate Cancer and Prostatic Diseases(2025)10.1038/s41391-025-01062-8

N/A

0DataRank · unranked

1 citations

Ralph Jiang, James A. Proudfoot, Elizabeth C. Chase, Krithika Suresh, Elai Davicioni +22 more

ATAD2 Drives Prostate Cancer Progression to Metastasis

Molecular Cancer Research(2025)10.1158/1541-7786.mcr-24-0544

N/A

0DataRank · unranked

3 citations

Antonio Rodríguez-Calero, Kacey Ronaldson-Bouchard, Anne Offermann, Daoud Rahman, Twinkle Bapuji Vhatkar +9 more

Disrupting the interaction between androgen receptor and its coregulator WDR77 delays the growth of treatment-resistant prostate cancer

Cell Reports(2025)10.1016/j.celrep.2025.116235

N/A

0DataRank · unranked

1 citations

Sangeeta Kumari, Nidhi Singh, Chitra Rawat, Eduardo Cortes Gomez, Yara Ghanem +12 more

Decipher score as a predictor of response to treatment intensification in the NRG Oncology-RTOG 0534 (SPPORT) phase III randomized post-prostatectomy salvage radiotherapy trial.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.5_suppl.399

N/A

0DataRank · unranked

3 citations

Marla Johnson, J. Proudfoot, Elai Davicioni, Alan Dal Pra, Jeff Simko +15 more

Transcriptome classification of PTEN inactivation to predict survival benefit from docetaxel at start of androgen deprivation therapy (ADT) for metastatic prostate cancer (PC): An ancillary study of the STAMPEDE trials.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.5003

N/A

0DataRank · unranked

2 citations

Peter Dutey‐Magni, Marina Parry, Larissa Mendes, Ashwin Sachdeva, J. Proudfoot +15 more

Genomic Predictors of Response to Metastasis-directed Therapy With or Without Androgen Deprivation Therapy

European Urology Oncology(2025)10.1016/j.euo.2025.07.007

N/A

0DataRank · unranked

0 citations

Kim Van der Eecken, Yang Song, Amol C. Shetty, Elai Davicioni, James A. Proudfoot +28 more

Genomic and clinical characterization of stromal infiltration markers in prostate cancer

Cancer(2020)10.1002/cncr.32688

N/A

0DataRank · unranked

14 citations

Mohammed Alshalalfa, Shuang G. Zhao, Himisha Beltran, William S. Chen, Fallon Chipidza +11 more

Downregulation of ANPEP Is Associated with Aggressive Prostate Cancer and Poor Disease-specific Outcomes

European Urology Open Science(2025)10.1016/j.euros.2025.12.011

N/A

0DataRank · unranked

0 citations

Purvish Trivedi, Shivanshu Awasthi, Amparo Serna, Jasreman Dhillon, Christopher J. Sweeney +14 more

Diversity in Androgen Receptor Action Among Treatment-naïve Prostate Cancers Is Reflected in Treatment Response Predictions and Molecular Subtypes

European Urology Open Science(2020)10.1016/j.euros.2020.10.002

N/A

0DataRank · unranked

11 citations

Qiang Hu, Yang Liu, Mohammed Alshalalfa, Xin Zhao, Irène Wang +12 more

Performance of clinicopathologic models in men with high risk localized prostate cancer: impact of a 22-gene genomic classifier

Prostate Cancer and Prostatic Diseases(2020)10.1038/s41391-020-0226-2

N/A

0DataRank · unranked

26 citations

Samuel R. Birer, R. Jeffrey Karnes, Jingbin Zhang, Elai Davicioni, Eric A. Klein +22 more

Somatic HOXB13 Expression Correlates with Metastatic Progression in Men with Localized Prostate Cancer Following Radical Prostatectomy

European Urology Oncology(2020)10.1016/j.euo.2020.05.001

N/A

0DataRank · unranked

24 citations

Farzana A. Faisal, Elai Davicioni, R. Jeffrey Karnes, Donald J. Vander Griend, Tamara L. Lotan +2 more

Luminal B subtype as a predictive biomarker of docetaxel benefit for newly diagnosed metastatic hormone sensitive prostate cancer (mHSPC): A correlative study of E3805 CHAARTED.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.162

N/A

0DataRank · unranked

18 citations

Victoria Wang, Yu‐Hui Chen, Felix Y. Feng, Robert B. Den, Gerhardt Attard +10 more

Characterization of PSMA and 18F-fluciclovine transporter gene expression in localized prostate cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.295

N/A

0DataRank · unranked

0 citations

Mohammed Alshalalfa, Martin Sjöström, Shuang G. Zhao, Annika Herlemann, Jonathan Chou +15 more

Plasma cells are enriched in localized prostate cancer in Black men and are associated with improved outcomes

Nature Communications(2021)10.1038/s41467-021-21245-w

N/A

0DataRank · unranked

114 citations

Thiago Vidotto, Yang Liu, Adrianna A. Mendes, Daniela C. Salles, Farzana A. Faisal +14 more

Patients with Muscle-Invasive Bladder Cancer with Nonluminal Subtype Derive Greatest Benefit from Platinum Based Neoadjuvant Chemotherapy

The Journal of Urology(2021)10.1097/ju.0000000000002261

N/A

0DataRank · unranked

59 citations

Joep J. de Jong, Vinnie Y. T. Liu, Tarek A. Bismar, Stephen A. Boorjian, Huei-Chung Huang +10 more

Elai Davicioni

Indexed papers

Top data-sharing exemplar

Papers